MARKET

SOLY

SOLY

SOLITON, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

21.96
-0.04
-0.18%
Closed 16:34 07/29 EDT
OPEN
22.00
PREV CLOSE
22.00
HIGH
22.14
LOW
21.94
VOLUME
398.40K
TURNOVER
--
52 WEEK HIGH
22.55
52 WEEK LOW
5.69
MARKET CAP
474.26M
P/E (TTM)
-26.8788
1D
5D
1M
3M
1Y
5Y
Soliton, Inc. (SOLY): Hedge Funds Are Snapping Up
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bou...
Insider Monkey · 06/18 15:38
--Roth Capital Downgrades Soliton to Neutral From Buy
MT Newswires · 06/02 07:02
Soliton, Inc. /Tx/ to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Soliton, Inc. /Tx/ (NASDAQ:SOLY) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 4:30 PM Eastern Time.
ACCESSWIRE · 05/13 18:34
With Abbvie acquisition, Cantor downgrades Soliton to neutral
Given an Abbvie (ABBV) subsidiary's recent announcement it would acquire Soliton (SOLY) and following the company's solid Q1 results, Cantor Fitzgerald is downgrading the stock to neutral.Analyst Louise Chen is
Seekingalpha · 05/13 16:19
Benzinga's Top Ratings Upgrades, Downgrades For May 13, 2021
 
Benzinga · 05/13 14:03
Soliton (SOLY) is in Overbought Territory: What's Next?
Soliton (SOLY) has moved higher as of late, but there could definitely be trouble on the horizon for this company
Zacks · 05/13 12:24
Cantor Fitzgerald Downgrades Soliton to Neutral, Lowers Price Target to $22.6
Cantor Fitzgerald analyst Louise Chen downgrades Soliton (NASDAQ:SOLY) from Overweight to Neutral and lowers the price target from $25 to $22.6.
Benzinga · 05/13 12:14
--Cantor Fitzgerald Downgrades Soliton to Neutral from Overweight, Adjusts Price Target to $22.60 from $25
MT Newswires · 05/13 09:36
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SOLY. Analyze the recent business situations of SOLITON, INC. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SOLY stock price target is 22.60 with a high estimate of 22.60 and a low estimate of 22.60.
EPS
Institutional Holdings
Institutions: 77
Institutional Holdings: 3.61M
% Owned: 16.72%
Shares Outstanding: 21.60M
TypeInstitutionsShares
Increased
12
247.15K
New
11
479.92K
Decreased
18
241.98K
Sold Out
4
100.61K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.96%
Healthcare Equipment & Supplies
+0.72%
Key Executives
Chairman/Co-Founder/Executive Director
Walter Klemp
President/Chief Executive Officer/Director
Bradley Hauser
Vice Chairman/Chief Scientific Officer/Director
Christopher Capelli
Chief Financial Officer/Executive Vice President
Lori Bisson
Chief Operating Officer
Joe Tanner
Independent Director
Jonathan Foster
Independent Director
Danika Harrison
Independent Director
Niquette Hunt
Independent Director
Michael Kaminer
No Data
About SOLY
Soliton Inc is a medical technology company. The Company is focused on developing and commercializing products utilizing its designed acoustic shockwave technology platform referred to as Rapid Acoustic Pulse (RAP). It develops products for the removal of tattoos and the reduction of cellulite. The RAP device in coordination with the pulsed laser removes ink pigment from the macrophages. Its RAP device uses pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue. It’s designed shockwave allows it to target the stiffness between cellular structures and generate an effect that represents a platform technology in tattoo removal, cellulite treatment, fibrotic scar treatment and other indications. Its technology allows the disruption of targeted structures within the skin with minimal discomfort and without additional treatment-related downtime for tattoo removal or any downtime for cellulite treatment.

Webull offers kinds of Soliton Inc stock information, including NASDAQ:SOLY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SOLY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SOLY stock methods without spending real money on the virtual paper trading platform.